Bio-Techne TECH 深 滬
等待開盤 09-23 09:30:00 美东时间
72.55
+0.080
+0.11%
華盛通- 最 高72.69
- 今 開72.52
- 成交量 344.15万股
- 最 低 72.46
- 昨 收 72.47
- 總市值 113.77亿
- 52周最高 72.69
- 市盈率 靜 62.64
- 換手率 2.19%
- 52周最低 43.035
- 委 比 63.24%
- 總股本 1.57亿
- 歷史最高 134.3625
- 量 比 0.86
- 振 幅 0.32%
- 歷史最低 11.5325
- 每 手 1
- 風險率 7.93%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Bio-Techne Announces SBTi Validation Of 70% Scope 1 & 2 Emissions Reduction Target By FY2031 And Supplier Engagement Commitment, Reporting Significant Operational Emissions Cuts In FY2026
Fiscal 2026 highlights: Science Based Targets initiative validates Bio-Techne's Scope 1, 2 and 3 greenhouse gas reduction targets Market-based Scope 1 and 2 emissions reduced 49% year-over-year More than half of the company's electricity consumption now comes from renewable sources First comprehensi...
09-01 18:36
财报速睇 | Bio-Techne 2026财年年度营收12.15亿美元，同比下降0.4%；归母净利润1.82亿美元，同比增长149.3%
华盛资讯8月25日讯，Bio-Techne公布2026财年年度业绩，公司年度营收12.15亿美元，同比下降0.4%，归母净利润1.82亿美元，同比增长149.3%。
08-25 04:47
美股大行评级 | 潜在涨幅544.53%！Scynexis获古根海姆升目标价至33美元，维持"买入"评级
今日重点评级关注：古根海姆：维持Scynexis"买入"评级，目标价从24美元升至33美元；韦德布什：维持Kura Oncology"跑赢大市"评级，目标价从36美元升至38美元
08-14 11:51
Wells Fargo Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73
Wells Fargo analyst Brandon Couillard downgrades Bio-Techne (NASDAQ:TECH) from Overweight to Equal-Weight and raises the price target from $62 to $73.
08-14 05:36
Bio-Techne Corrects Dividend Announcement
MINNEAPOLIS, Aug. 13, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) is issuing a correction to its dividend announcement released yesterday. The initial version incorrectly stat...
08-13 18:30
Bio-Techne declares $0.08 dividend
Bio-Techne (TECH) declares $0.08/share quarterly dividend, in line with previous. Forward yield 0.44% Payable Aug. 28; for shareholders of record Aug. 17; ex-div Aug. 17. See TECH Dividend Scorecard, ...
08-12 18:54
财报速睇 | Bio-Techne 2026财年Q2营收3.21亿美元，同比增长1.3%；归母净利润0.55亿美元，扭亏为盈
华盛资讯8月12日讯，Bio-Techne公布2026财年Q2业绩，公司Q2营收3.21亿美元，同比增长1.3%，归母净利润0.55亿美元，扭亏为盈。
08-12 18:47
Bio-Techne Q4 Adj. EPS $0.52, Inline, Sales $321.191M Beat $314.679M Estimate
Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.52 per share which met the analyst consensus estimate. This is a 1.89 percent decrease over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $321.191 million which beat the analyst consensus...
08-12 18:41
Bio-Techne Declares Dividend
MINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended ...
08-12 18:30
